We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookies Policy
Accept
AsolicaAsolicaAsolica
  • Home
  • Business
  • Crypto
  • Finance
  • Marketing
  • Startup
Reading: Main well being care product firm information for Chapter 11 chapter
Share
Font ResizerAa
AsolicaAsolica
Font ResizerAa
  • Home
  • Business
  • Crypto
  • Finance
  • Marketing
  • Startup
Follow US
© 2025 Asolica News Network. All Rights Reserved.
Asolica > Blog > Finance > Main well being care product firm information for Chapter 11 chapter
Finance

Main well being care product firm information for Chapter 11 chapter

Admin
Last updated: October 11, 2025 3:03 am
Admin
2 weeks ago
Share
Main well being care product firm information for Chapter 11 chapter
SHARE

The elevated price of chapter filings by well being care suppliers, organizations, and hospitals over the earlier two years has slowed down in 2025 with lower than one-third as many petitions filed to this point this yr, primarily based on knowledge from Becker’s Hospital Assessment.

Contents
    • Yearly well being care chapter filings:
  • Navidea Biopharmaceuticals information for chapter safety
  • Navidea seeks debtor-in-possession financing
  • Navidea sells rights to a key drug
    • Navidea’s sale of Lymphoseek particulars:
  • Litigation, failed trials, involuntary chapter threats drive Chapter 11

The well being care trade has recorded no less than 18 chapter filings this yr as of the primary week of October 2025.

That is considerably fewer than the 57 filings for the yr in 2024 and 79 instances in 2023. It is also fewer than half the annual submitting common of 42 annually from 2019 via 2022, in accordance with Gibbins Advisors.

Yearly well being care chapter filings:

  • Well being care bankruptcies, Jan.-Oct. 2025: 18
  • Well being care bankruptcies, 2024: 57
  • Well being care bankruptcies, 2023: 79

Among the many main filings this yr has been well being care services operator Genesis Healthcare Inc., which filed for Chapter 11 chapter on July 9, with over $708 million in secured debt and over $1.5 billion in unsecured debt.

Additionally, large well being care providers supplier ModivCare Inc. and 70 associates filed for a prearranged Chapter 11 chapter on Aug. 20, in search of to cut back their $1.4 billion in debt and hand their belongings to prepetition lenders, dealing with an unsustainable capital construction, deteriorating liquidity, and trade headwinds.


Navidea Biopharmaceuticals has filed for chapter.

Getty Pictures

Navidea Biopharmaceuticals information for chapter safety

And now, troubled biopharmaceutical firm Navidea Biopharmaceuticals Inc. has filed for Chapter 11 safety, dealing with monetary misery after years of litigation, provide chain points, and a current risk of an involuntary chapter petition.

The Columbus, Ohio-based debtor listed $1 million to $10 million in belongings and $10 million to $50 million in liabilities in its Subchapter V petition filed on Oct. 1. The corporate mentioned in it submitting that it had $1.2 million in belongings and $12.8 million in liabilities as of Aug. 31, 2025.

The corporate’s largest unsecured collectors embrace Winstead PC, owed over $566,000; Fredrickson & Byron P.A., owed over $479,000; and WorldCare Clinic LLC, owed over $255,000.

Navidea seeks debtor-in-possession financing

Navidea filed a movement in search of approval of as much as $940,000 in debtor-in-possession financing from its secured creditor John Kimball Scott Jr., a member of the corporate’s board of administrators, who’s owed $7.76 million in debt.

The biopharmaceutical firm develops precision drugs with immuno-targeted merchandise, together with Lymphoseek, a first-of-its-kind product that assists within the prognosis of metastatic cancers which will have unfold to lymph nodes and likewise assists within the staging course of.

Navidea sells rights to a key drug

Navidea reached an settlement in November 2016 to promote its North American Lymphoseek belongings to Cardinal Well being. The deal closed in March 2017, for $80 million upfront.

Subsequently, the biopharmaceutical firm accepted a lump sum of a further $17 million, discounted money movement fee in lieu of future royalties of an estimated $165 million on future Lymphoseek gross sales.

Navidea’s sale of Lymphoseek particulars:

  • North American Lymphoseek belongings, $80 million upfront to Navidea, closes March 2017.
  • $17 million fee in lieu of future royalties estimated at $165 million, earlier than February 2018.

The sale excluded all belongings, properties, and rights outdoors of North America.

Capital Royalty Companions II LP had supplied the debtor with a $50 million mortgage in 2015, which grew to $66 million after a default and litigation, in accordance with court docket papers. Navidea paid the lender $59 million after the sale to Cardinal Well being was accomplished in December 2017.

Litigation, failed trials, involuntary chapter threats drive Chapter 11

Navidea was additionally engaged in lawsuits and countersuits with former CEO Dr. Michael Goldberg, from February 2019 to December 2024.

Moreover, prices from failed medical trials, world provide chain points, and threats of doable involuntary chapter filings prompted Navidea to file for Chapter 11 safety.

Associated: 79-year-old key well being care supplier information Chapter 11 chapter

AT&T’s harsh new coverage for workers hits a snag
Oracle soars, TSMC & Broadcom emerge winners: Market Wrap
Las Vegas Strip Mexican restaurant closing for good
Walmart is promoting a 'stunning and sturdy' $800 chaise lounge patio chair for under $100
Amazon makes harsh product change, angering prospects 
TAGGED:bankruptcycareChaptercompanyfilesHealthmajorproduct
Share This Article
Facebook Email Print
Previous Article Perplexity’s 31-year-old CEO horrified after getting tagged by a pupil utilizing his free AI browser to cheat: ‘Absolutely don’t do that’ | Fortune Perplexity’s 31-year-old CEO horrified after getting tagged by a pupil utilizing his free AI browser to cheat: ‘Absolutely don’t do that’ | Fortune
Next Article US–China Tariff Fears Hit Bitcoin Treasury Shares – BeInCrypto US–China Tariff Fears Hit Bitcoin Treasury Shares – BeInCrypto
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow
Popular News
Rates of interest and the FTSE 100: how are markets affected?
Marketing

Rates of interest and the FTSE 100: how are markets affected?

Admin
By Admin
1 month ago
Walmart is promoting a 'heat' $40 wearable fleece blanket for simply $21
Walmart is promoting a $415 Seiko look ahead to $245 that's each 'elegant and sporty'
How a lot do you want in a Shares and Shares ISA to retire comfortably in 2025?
T-Cell plans a harsh change for patrons after new CEO begins

You Might Also Like

77-year-old in style furnishings retailer closes retailer places

77-year-old in style furnishings retailer closes retailer places

1 week ago
Disney World quietly raises key worth with no fanfare

Disney World quietly raises key worth with no fanfare

3 weeks ago
Inventory Market Right now: Nike, Eli Lily surge; Robinhood slips

Inventory Market Right now: Nike, Eli Lily surge; Robinhood slips

4 weeks ago
Amazon is promoting a pair of noise-canceling wi-fi earbuds for simply

Amazon is promoting a pair of noise-canceling wi-fi earbuds for simply $25

1 month ago
about us

Welcome to Asolica, your reliable destination for independent news, in-depth analysis, and global updates.

  • Home
  • Business
  • Crypto
  • Finance
  • Marketing
  • Startup
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Disclaimer
  • Terms & Conditions

Find Us on Socials

© 2025 Asolica News Network. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?